Status:

COMPLETED

Self Medication With Oral Morphine After Total Knee Arthroplasty.

Lead Sponsor:

The Royal Bournemouth Hospital

Collaborating Sponsors:

Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

Conditions:

Arthroplasty, Knee Replacement

Pain Control

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The study aims to compare two post operative pain management strategy's, traditional nurse dispensed pain control versus patient self medication. The investigators aim to establish if patients who sel...

Eligibility Criteria

Inclusion

  • Patients requiring total knee replacement surgery willing to provide written, informed consent.

Exclusion

  • Unable to safely self medicate.
  • Allergy to morphine.
  • Unable to provide consent.
  • Contraindication to the standardised anaesthetic or standard postoperative care.
  • Not consenting to an element of the standardised anaesthetic.
  • Pre-operative use of strong opiates e.g. Oramorph, MST, Oxynorm.

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2011

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT01226186

Start Date

October 1 2010

End Date

June 1 2011

Last Update

December 4 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Derwent Unit, Royal Bournemouth Hospital.

Bournemouth, Dorset., United Kingdom, BH7 7DW